Published in Clin Cancer Res on December 15, 2004
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer (2008) 3.04
DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis. J Bone Miner Res (2005) 2.46
Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res (2009) 2.34
Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer. Cancer Res (2006) 1.35
DSPP effects on in vivo bone mineralization. Bone (2008) 1.19
The NH2-terminal and COOH-terminal fragments of dentin matrix protein 1 (DMP1) localize differently in the compartments of dentin and growth plate of bone. J Histochem Cytochem (2008) 1.19
Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. World J Gastroenterol (2012) 1.10
Distribution of small integrin-binding ligand, N-linked glycoproteins (SIBLING) in the condylar cartilage of rat mandible. Int J Oral Maxillofac Surg (2010) 1.04
Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells. J Cell Physiol (2009) 0.99
Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44. Cancer Res (2005) 0.98
Dentin sialophosphoprotein and dentin matrix protein-1: Two highly phosphorylated proteins in mineralized tissues. Arch Oral Biol (2012) 0.96
Influence of TGF-beta1 on the expression of BSP, DSP, TGF-beta1 receptor I and Smad proteins during reparative dentinogenesis. J Mol Histol (2007) 0.95
Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial. Clin Cancer Res (2011) 0.93
Distribution of small integrin-binding ligand, N-linked glycoproteins (SIBLING) in the articular cartilage of the rat femoral head. J Histochem Cytochem (2010) 0.93
Immunolocalization of sibling and RUNX2 proteins during vertical distraction osteogenesis in the human mandible. J Histochem Cytochem (2007) 0.93
Possible role of DMP1 in dentin mineralization. J Struct Biol (2010) 0.92
Expression and distribution of SIBLING proteins in the predentin/dentin and mandible of hyp mice. Oral Dis (2010) 0.90
Small integrin-binding proteins as serum markers for prostate cancer detection. Clin Cancer Res (2009) 0.89
Generation of a conditional null allele for Dmp1 in mouse. Genesis (2008) 0.89
Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients. J Cancer Res Clin Oncol (2014) 0.89
Bone sialoprotein binding to matrix metalloproteinase-2 alters enzyme inhibition kinetics. Biochemistry (2008) 0.86
Extracellular molecules involved in cancer cell invasion. Cancers (Basel) (2015) 0.85
High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients. PLoS One (2012) 0.83
Structural requirements for bone sialoprotein binding and modulation of matrix metalloproteinase-2. Biochemistry (2008) 0.80
Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2. PLoS One (2010) 0.80
Dentin matrix protein 1 and phosphate homeostasis are critical for postnatal pulp, dentin and enamel formation. Int J Oral Sci (2012) 0.80
Immunohistochemical localization of the NH(2)-terminal and COOH-terminal fragments of dentin sialoprotein in mouse teeth. Cell Tissue Res (2012) 0.79
Differential expression and localization of dentin matrix protein 1 (DMP1) fragments in mouse submandibular glands. J Mol Histol (2012) 0.78
Adhesive and migratory effects of phosphophoryn are modulated by flanking peptides of the integrin binding motif. PLoS One (2014) 0.77
Dmp1 Null Mice Develop a Unique Osteoarthritis-like Phenotype. Int J Biol Sci (2016) 0.75
Expression of the SIBLINGs and their MMP partners in human benign and malignant prostate neoplasms. Oncotarget (2016) 0.75
Matricellular proteins as regulators of cancer metastasis to bone. Matrix Biol (2016) 0.75
Cancer Secretome May Influence BSP and DSP Expression in Human Salivary Gland Cells. J Histochem Cytochem (2016) 0.75
Dentine matrix protein 1 (DMP-1) is a marker of bone formation and mineralisation in soft tissue tumours. Virchows Arch (2015) 0.75
Alteration of bone sialoprotein expression in osseous metastasized renal cell carcinomas and the tumor surrounding tissue. Clin Exp Metastasis (2011) 0.75
Osteopontin -- a promising biomarker for cancer therapy. J Cancer (2017) 0.75
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest (2003) 3.60
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer (2008) 3.04
Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res (2003) 3.03
Identification and characterization of a functional mitochondrial angiotensin system. Proc Natl Acad Sci U S A (2011) 2.16
ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci (2008) 2.09
Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J (2004) 1.79
Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev (2004) 1.76
Gene expression profiling identifies markers of ampullary adenocarcinoma. Cancer Biol Ther (2004) 1.74
Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease. Int J Geriatr Psychiatry (2012) 1.47
Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer. Cancer Res (2006) 1.35
The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis. J Clin Endocrinol Metab (2006) 1.28
Determination of the elimination half-life of fibroblast growth factor-23. J Clin Endocrinol Metab (2007) 1.27
Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack. J Biol Chem (2002) 1.21
Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D. J Bone Miner Res (2005) 1.14
Impact on bone of an estrogen receptor-alpha gene loss of function mutation. J Clin Endocrinol Metab (2008) 1.12
Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty. Cytokine (2009) 1.08
Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14(+) monocytes in frail older adults. Mech Ageing Dev (2008) 1.08
T-lymphocytes expressing CC chemokine receptor-5 are increased in frail older adults. J Am Geriatr Soc (2008) 1.05
Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. J Gerontol A Biol Sci Med Sci (2010) 1.03
Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion. J Natl Cancer Inst (2004) 1.02
IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults. Age Ageing (2011) 1.00
Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44. Cancer Res (2005) 0.98
Serum markers of apoptosis decrease with age and cancer stage. Aging (Albany NY) (2009) 0.97
WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone. PLoS One (2013) 0.95
Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma. J Alzheimers Dis (2010) 0.94
Small integrin-binding proteins as serum markers for prostate cancer detection. Clin Cancer Res (2009) 0.89
Serum chitotriosidase, a putative marker of chronically activated macrophages, increases with normal aging. J Gerontol A Biol Sci Med Sci (2013) 0.87
Activation of (Na+ + K+)-ATPase induces positive inotropy in intact mouse heart in vivo. Biochem Biophys Res Commun (2006) 0.87
Bone sialoprotein binding to matrix metalloproteinase-2 alters enzyme inhibition kinetics. Biochemistry (2008) 0.86
Age-related changes in human bone proteoglycan structure. Impact of osteogenesis imperfecta. J Biol Chem (2002) 0.83
Elevated levels of neopterin in sleep-disordered breathing. Chest (2007) 0.83
The short-term and long-term impact of a brief aging research training program for medical students. Gerontol Geriatr Educ (2014) 0.82
Structural requirements for bone sialoprotein binding and modulation of matrix metalloproteinase-2. Biochemistry (2008) 0.80
Matrix extracellular phosphoglycoprotein (MEPE) correlates with serum phosphorus prior to and during octreotide treatment and following excisional surgery in hypophosphatemic linear sebaceous nevus syndrome. Am J Med Genet A (2008) 0.80
"Speed dating" as a technique to efficiently align mentees and mentors in a geriatrics training program. J Am Geriatr Soc (2010) 0.79
Surgical blood loss during femoral rodding in children with osteogenesis imperfecta. J Child Orthop (2009) 0.78
Changes in bone biomarker concentrations and musculoskeletal symptoms among breast cancer patients initiating aromatase inhibitor therapy and women without a history of cancer. J Bone Miner Res (2012) 0.75